Location: Home
  • search
  • go
  • Relate News
  • 4/19/2025HighTide's HTD1801 Meets Goals in Two Phase 3 Diabetes Trials
  • 4/19/2025China Approves AstraZeneca's Truqap for Advanced HR+/HER2– Breast Can...
  • 4/19/2025Akeso's Ebdarokimab Approved in China as First Domestic IL-12/IL-23 An...
  • 4/19/2025Haleon Achieves Full Ownership of Tianjin SmithKline JV
  • 4/19/2025China Issues New Guidelines to Streamline Mainland Registration for Or...
  • 4/18/2025VelaVigo and Ollin Biosciences Ink ex-Greater China Licensing Deal for...
  • 4/18/2025WuXi Biologics Completes 15,000L PPQ at Hangzhou Site
  • 4/18/2025Chinese drugmakers weigh options as US mulls pharma tariffs (KrAsia)
  • 4/17/2025This Pharma Company Is Betting Big On A Chinese Ozempic Rival (Forbes)
  • 4/17/2025Interpretation of the Anti-Monopoly Guidelines for Pharmaceutical Sect...
  • 4/17/2025BMS Launches Head-to-Head Phase 1 Trial for SystImmune-Licensed EGFR/H...
  • 4/17/2025DualityBio Raises $211M in Hong Kong IPO
  • 4/17/2025InnoCare's Zurletrectinib NDA Accepted by China's NMPA for NTRK Fusion...
  • 4/17/2025Eli Lilly's Mirikizumab Advances in China with New Indication Filing
  • 4/17/2025Akeso Advances Second ADC into Clinical Trials with TROP2/Nectin-4 Bis...
  • 4/17/2025Sanofi Secures Global Rights to AI-Discovered BsAb in $1.8B+ Deal with...
  • 4/17/2025Hengrui Advances CD79b-Targeted ADC SHR-A1912 into Phase 3 Trial for R...
  • 4/17/2025Latticon Pioneers China's First Pipeline-Backed Financing Deal
  • 4/17/2025Eddingpharm to Take Over Genor in HKEX's First 18A Reverse Merger
  • 4/17/2025WuXi AppTec Cashes Out of WuXi XDC as U.S. Tariff Threats Mount
  • 4/17/2025Pharma Giants Already Moving to Cut Reliance on China Amid Tariff Unce...
  • 4/15/2025Gardasil9 Gains Expanded Approval in China
  • 4/15/2025China NMPA Approves Kowa's Parmodia (Pemafibrate) for Dyslipidemia Tre...
  • 4/15/2025Chinese Pharma Companies Rethink Global Strategies as US Considers Dru...
  • 4/15/2025U.S. Tariff Threat on Chinese Pharma Could Reshape Landscape for India...
  • 4/15/2025Akeso Initiates First Clinical Trial for AK139, Its First Non-Oncology...
  • 4/15/2025Off-Label Drug Use in China After the Physician Law (2021): Legal Chal...
  • 4/14/2025Trump vs China Biotech: Who Will Emerge Victorious in the Tariff Trade...
  • 4/14/2025China's Online Pharmacy Market Surpasses CNY 70B: WMs Gain Ground as D...
  • 4/14/2025Sirius Receives FDA IND Clearance for FIC siRNA Therapy SRSD216 Target...
  • Page:1/761 Total number of articles:22823: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group